Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
Clinical and Molecular Hepatology · 2023
DOI: 10.3350/cmh.2023.0035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, 2023. Verfasst von Hong-Kyu Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Subdivision of Endocrinology and Metabolism, Health Screening and Promotion Center, Asan Medical Center, Seoul, Korea. Hauptthemen laut MEDLINE: Sarcopenia, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background/Aims: To investigate whether non-alcoholic fatty liver disease (NAFLD) in individuals without generalized obesity is associated with visceral fat obesity (VFO), sarcopenia, and/or myosteatosis.
Methods
This cross-sectional analysis included 14,400 individuals (7,470 men) who underwent abdominal computed tomography scans during routine health examinations. The total abdominal muscle area (TAMA) and skeletal muscle area (SMA) at the 3rd lumbar vertebral level were measured. The SMA was divided into the normal attenuation muscle area (NAMA) and low attenuation muscle area, and the NAMA/TAMA index was calculated. VFO was defined by visceral to subcutaneous fat ratio, sarcopenia by body mass index-adjusted SMA, and myosteatosis by the NAMA/TAMA index. NAFLD was diagnosed with ultrasonography.
Results
Of the 14,400 individuals, 4,748 (33.0%) had NAFLD, and the prevalence of NAFLD among non-obese individuals was 21.4%. In regression analysis, both sarcopenia (men: odds ratio [OR] 1.41, 95% confidence interval [CI] 1.19–1.67, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Subdivision of Endocrinology and Metabolism, Health Screening and Promotion Center, Asan Medical Center, Seoul, Korea.
- Subdivision of Gastroenterology and Hepatology, Health Screening and Promotion Center, Asan Medical Center, Seoul, Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Asan Diabetes Center, Asan Medical Center, Seoul, Korea.
Zitieren
APA
Kim, H. K., Bae, S. J., Lee, M. J., Kim, E. H., Park, H., Kim, H. S., Cho, Y. K., Jung, C. H., Lee, W. J., & Choe, J. (2023). Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2023.0035
Vancouver
Kim HK, Bae SJ, Lee MJ, Kim EH, Park H, Kim HS, et al. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity. Clinical and Molecular Hepatology. 2023. doi:10.3350/cmh.2023.0035
BibTeX
@article{Kim2023,
author = {Kim, Hong-Kyu and Bae, Sung-Jin and Lee, Min Jung and Kim, Eun Hee and Park, Hana and Kim, Hwi Seung and Cho, Yun Kyung and Jung, Chang Hee and Lee, Woo Je and Choe, Jaewon},
title = {Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity},
journal = {Clinical and Molecular Hepatology},
year = {2023},
doi = {10.3350/cmh.2023.0035}
}
EUVIMED